Predicting recurrence patterns after resection of hepatocellular cancer Journal Article


Authors: Lee, S. Y.; Konstantinidis, I. T.; Eaton, A. A.; Gonen, M.; Kingham, T. P.; D'Angelica, M. I.; Allen, P. J.; Fong, Y. M.; DeMatteo, R. P.; Jarnagin, W. R.
Article Title: Predicting recurrence patterns after resection of hepatocellular cancer
Abstract: Background: The reliable prediction of hepatocellular carcinoma (HCC) recurrence patterns potentially allows for the prioritization of patients for liver resection (LR) or transplantation. Objectives: The aim of this study was to analyse clinicopathological factors and preoperative Milan criteria (MC) status in predicting patterns of HCC recurrence. Methods: During 1992-2012, 320 patients undergoing LR for HCC were categorized preoperatively as being within or beyond the MC, as were recurrences. Results: After a median follow-up of 47 months, 183 patients developed recurrence, giving a 5-year cumulative incidence of recurrence of 62.5%. Patients with preoperative disease within the MC had better survival outcomes than those with preoperative disease beyond the MC (median survival: 102 months versus 45 months; P < 0.001). Overall, 31% of patients had preoperative disease within the MC and 69% had preoperative disease beyond the MC. Estimated rates of recurrence-free survival at 5 years were 61.8% for all patients and 53.8% for patients with initial beyond-MC status. Independent factors for recurrence beyond-MC status included preoperative disease beyond the MC, the presence of microsatellite or multiple tumours and lymphovascular invasion (all: P < 0.001). A clinical risk score was used to predict survival and the likelihood of recurrence beyond the MC; patients with scores of 0, 1, 2 and 3 had 5-year incidence of recurring beyond-MC of 9.0%, 29.5%, 48.8% and 75.4%, respectively (P < 0.0001). Conclusions: Regardless of initial MC status, at 5 years the majority of patients remained disease-free or experienced recurrence within the MC after LR, and thus were potentially eligible for salvage transplantation (ST). Incorporating clinicopathological parameters into the MC allows for better risk stratification, which improves the selection of patients for ST and identifies patients in need of closer surveillance.
Keywords: carcinoma; hepatectomy; resection; surgical; long-term survival; risk-factors; criteria; to-treat analysis; salvage transplantation; preserved liver-function; milan; microvascular invasion
Journal Title: HPB
Volume: 16
Issue: 10
ISSN: 1365-182X
Publisher: Elsevier Science, Inc.  
Date Published: 2014-10-01
Start Page: 943
End Page: 953
Language: English
ACCESSION: WOS:000342130600011
DOI: 10.1111/hpb.12311
PROVIDER: wos
PUBMED: 25041404
PMCID: PMC4238862
Notes: Article; Proceedings Paper -- Annual Meeting of the Americas-Hepato-Pancreato-Biliary-Association -- FEB 10-23, 2014 -- Miami, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald P DeMatteo
    637 DeMatteo
  2. Mithat Gonen
    1028 Gonen
  3. Peter Allen
    501 Allen
  4. William R Jarnagin
    903 Jarnagin
  5. Yuman Fong
    775 Fong
  6. T Peter Kingham
    609 Kingham
  7. Anne Austin Eaton
    122 Eaton
  8. Ser Yee Lee
    9 Lee